Santhera Pharmaceuticals Holding AG (SPHDF)
18.30
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Santhera Pharmaceuticals Cash from Operations (Annual) : -41.86M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -41.86M |
| December 31, 2024 | -40.34M |
| December 31, 2023 | 52.60M |
| December 31, 2022 | -31.25M |
| December 31, 2021 | -40.86M |
| December 31, 2020 | -46.36M |
| December 31, 2019 | 2.611M |
| December 31, 2018 | -38.69M |
| December 31, 2017 | -40.27M |
| December 31, 2016 | -27.55M |
| December 31, 2015 | -23.25M |
| December 31, 2014 | -6.623M |
| Date | Value |
|---|---|
| December 31, 2013 | -7.525M |
| December 31, 2012 | -11.77M |
| December 31, 2011 | -22.44M |
| December 31, 2010 | -6.367M |
| December 31, 2009 | -19.12M |
| December 31, 2008 | -42.20M |
| December 31, 2007 | -16.63M |
| December 31, 2006 | -19.08M |
| December 31, 2005 | -4.919M |
| December 31, 2004 | -14.58M |
| December 31, 2003 | -10.89M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Basilea Pharmaceutica AG | 74.76M |
| BeOne Medicines Ltd. | 1.131B |
| AC Immune SA | -83.40M |
| CRISPR Therapeutics AG | -345.01M |
| Idorsia Ltd. | -203.32M |